Lidocaine Hydrochloride Solution
Product Images NDC 51672-1411

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 51672-1411). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lidocaine-02 (Lidocaine 02)

Lidocaine-02 (Lidocaine 02)
This text appears to be a description for a medication called Lidocaine Hydrochloride Topical Solution USP, 4%. The text includes information about the dosage, warnings, and storage instructions for the medication. It also mentions that the solution is not for injection and should only be used topically. The solution contains 140 mg of lidocaine hydrochloride USP per mL. Additionally, it states that the solution also contains methylparaben and sodium hydroxide for pH adjustment. The manufacturer is Taro Pharmaceuticals, with locations in Canada and the USA. The text also includes some technical details such as NDC and pharmacode numbers. Overall, this text provides information about the usage and composition of Lidocaine Hydrochloride Topical Solution.*
FDA Label Image

Structural-formula (Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.